These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8891480)

  • 41. Activation of the IL-6/JAK/STAT3 signaling pathway in human middle ear cholesteatoma epithelium.
    Liu W; Xie S; Chen X; Rao X; Ren H; Hu B; Yin T; Xiang Y; Ren J
    Int J Clin Exp Pathol; 2014; 7(2):709-15. PubMed ID: 24551293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Partial Epithelial-Mesenchymal Transition Was Observed Under p63 Expression in Acquired Middle Ear Cholesteatoma and Congenital Cholesteatoma.
    Takahashi M; Yamamoto-Fukuda T; Akiyama N; Motegi M; Yamamoto K; Tanaka Y; Yamamoto Y; Kojima H
    Otol Neurotol; 2019 Sep; 40(8):e803-e811. PubMed ID: 31348131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of bone morphogenetic protein-2 messenger ribonucleic acid in cholesteatoma fibroblasts.
    Schmidt M; Schler G; Gruensfelder P; Hoppe F
    Otol Neurotol; 2002 May; 23(3):267-70. PubMed ID: 11981380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
    Woo HJ; Park JC; Bae CH; Song SY; Lee HM; Kim YD
    Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential expression of human beta defensin 2 and human beta defensin 3 in human middle ear cholesteatoma.
    Song JJ; Chae SW; Woo JS; Lee HM; Jung HH; Hwang SJ
    Ann Otol Rhinol Laryngol; 2007 Mar; 116(3):235-40. PubMed ID: 17419529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased expression of p63 and survivin in cholesteatomas.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim HJ
    Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of matrix metalloproteinases in keratinocytes by cholesteatoma debris and granulation tissue extracts.
    Schmidt M; Grünsfelder P; Hoppe F
    Eur Arch Otorhinolaryngol; 2000; 257(8):425-9. PubMed ID: 11073191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The significance of keratinocyte in hyperproliferation of middle ear cholesteatoma].
    Zhu Z; Hong Y; Wang Y; He G; Ye S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jan; 30(2):139-43. PubMed ID: 27192911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cholesteatoma-associated fibroblasts modulate epithelial growth and differentiation through KGF/FGF7 secretion.
    Raffa S; Leone L; Scrofani C; Monini S; Torrisi MR; Barbara M
    Histochem Cell Biol; 2012 Aug; 138(2):251-69. PubMed ID: 22481617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The expressions and correlations of RAR-beta receptors and galectin-8 in human middle ear cholesteatoma].
    Peng L; Cui Y; Liu A
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):427-9. PubMed ID: 15499989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha.
    Schulz P; Bujía J; Holly A; Shilling V; Kastenbauer E
    Am J Otolaryngol; 1993; 14(2):82-7. PubMed ID: 8484481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Expression and significance of PTEN, P-ERK and P-AKT in the middle ear cholesteatoma].
    Liu D; Ma X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Feb; 28(4):238-42, 245. PubMed ID: 24800539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative analysis of the expression of E-cadherin, β-catenin, and β1 integrin in congenital and acquired cholesteatoma.
    Lee DW; Chung JH; Lee SH; Park CW; Kang SH; Oh YH; Pyo JY
    Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):845-51. PubMed ID: 25864182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical study of cell proliferation using BrdU labelling on tympanic membrane, external auditory canal and induced cholesteatoma in Mongolian gerbils.
    Park K; Chun YM; Park HJ; Lee YD
    Acta Otolaryngol; 1999; 119(8):874-9. PubMed ID: 10728926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p53 Expression and keratinocyte hyperproliferation in middle ear cholesteatoma.
    Motamed M; Powe D; Kendall C; Birchall JP; Banerjee AR
    Clin Otolaryngol Allied Sci; 2002 Dec; 27(6):505-8. PubMed ID: 12472520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expressions of caspase-14 in human middle ear cholesteatoma.
    Jung MH; Lee JH; Cho JG; Jung HH; Hwang SJ; Chae SW
    Laryngoscope; 2008 Jun; 118(6):1047-50. PubMed ID: 18520823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. EGFR expression in acquired middle ear cholesteatoma in children and adults.
    Alves AL; Pereira CS; Carvalho Mde F; Fregnani JH; Ribeiro FQ
    Eur J Pediatr; 2012 Feb; 171(2):307-10. PubMed ID: 21800041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Expression of epidermal growth factor receptor Ki67 and p16 in human middle ear cholesteatoma].
    Li S; Zhan H; Peng S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Nov; 22(21):987-91. PubMed ID: 19157151
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acquired cholesteatoma epithelial hyperproliferation: Roles of cell proliferation signal pathways.
    Xie S; Xiang Y; Wang X; Ren H; Yin T; Ren J; Liu W
    Laryngoscope; 2016 Aug; 126(8):1923-30. PubMed ID: 26989841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Markers of epidermal proliferation in middle ear cholesteatoma].
    Hassmann-Poznańska E; Skotnicka B; Dziecioł J
    Otolaryngol Pol; 2003; 57(4):505-11. PubMed ID: 14587387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.